Award
National Institute of Allergy and Infectious Diseases 5U01AI155299-05
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
Recipient
Vanderbilt University Medical Center
Award Amount
$1,583,667.00
Ceiling
$1,583,667.00
Awarded
April 28, 2025
Identifier
5U01AI155299-05
NIH awarded a grant to Vanderbilt University Medical Center for clinical research on GLP-1 receptor agonist treatment in adult obesity-related symptomatic asthma, involving a randomized controlled trial and mechanistic studies.
Description
This is a NIH grant project for clinical research on asthma treatment using GLP-1 receptor agonists. The project involves a randomized controlled trial, mechanistic studies, and aims to develop novel treatments for obese asthma phenotypes.